HTGM logo

HTGM Stock

Profile

Full Name:

HTG Molecular Diagnostics, Inc.

Sector:

Healthcare

Country:

United States

IPO:

06 May 2015

Indexes:

Not included

Description:

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Nov 10, 2021

Recent annual earnings:

Mar 25, 2021
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Dec 21, 2022

Analyst ratings

Recent major analysts updates

19 Apr '23 HC Wainwright & Co.
Buy
03 Apr '23 HC Wainwright & Co.
Buy
15 Aug '22 HC Wainwright & Co.
Buy
16 May '22 HC Wainwright & Co.
Buy
31 Mar '22 HC Wainwright & Co.
Buy
30 Mar '22 Craig-Hallum
Buy
07 Jan '22 Craig-Hallum
Buy
14 May '21 SVB Leerink
Outperform
14 May '21 HC Wainwright & Co.
Buy
26 Mar '21 HC Wainwright & Co.
Buy

Screeners with HTGM included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Similar stocks

Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?
Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?
Why Is HTG Molecular Diagnostics (HTGM) Stock Down 42% Today?
HTGM
InvestorPlace06 June 2023

HTG Molecular Diagnostics (NASDAQ: HTGM ) stock is falling on Tuesday after the company announced a Chapter 11 bankruptcy filing. According to this filing, HTG Molecular Diagnostics will operate as a “debtor-in-possession” business during the bankruptcy.

FAQ

  • What is the primary business of HTG Molecular Diagnostics?
  • What is the ticker symbol for HTG Molecular Diagnostics?
  • Does HTG Molecular Diagnostics pay dividends?
  • What sector is HTG Molecular Diagnostics in?
  • What industry is HTG Molecular Diagnostics in?
  • What country is HTG Molecular Diagnostics based in?
  • When did HTG Molecular Diagnostics go public?
  • Is HTG Molecular Diagnostics in the S&P 500?
  • Is HTG Molecular Diagnostics in the NASDAQ 100?
  • Is HTG Molecular Diagnostics in the Dow Jones?
  • When was HTG Molecular Diagnostics's last earnings report?
  • When does HTG Molecular Diagnostics report earnings?
  • Should I buy HTG Molecular Diagnostics stock now?

What is the primary business of HTG Molecular Diagnostics?

HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-oncology panel; HTG EdgeSeq miRNA whole-transcriptome assay; HTG EdgeSeq DLBCL cell of origin assay EU; HTG EdgeSeq Oncology Biomarker Panel; HTG immune response panel; and HTG mouse mRNA tumor response panel. The company distributes its instruments and consumables directly in the United States and Europe; and through distributors in parts of Europe and internationally. It serves biopharmaceutical companies, academic research centers, and molecular testing laboratories. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona. On June 5, 2023, HTG Molecular Diagnostics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

What is the ticker symbol for HTG Molecular Diagnostics?

The ticker symbol for HTG Molecular Diagnostics is NASDAQ:HTGM

Does HTG Molecular Diagnostics pay dividends?

No, HTG Molecular Diagnostics does not pay dividends

What sector is HTG Molecular Diagnostics in?

HTG Molecular Diagnostics is in the Healthcare sector

What industry is HTG Molecular Diagnostics in?

HTG Molecular Diagnostics is in the Diagnostics & Research industry

What country is HTG Molecular Diagnostics based in?

HTG Molecular Diagnostics is headquartered in United States

When did HTG Molecular Diagnostics go public?

HTG Molecular Diagnostics's initial public offering (IPO) was on 06 May 2015

Is HTG Molecular Diagnostics in the S&P 500?

No, HTG Molecular Diagnostics is not included in the S&P 500 index

Is HTG Molecular Diagnostics in the NASDAQ 100?

No, HTG Molecular Diagnostics is not included in the NASDAQ 100 index

Is HTG Molecular Diagnostics in the Dow Jones?

No, HTG Molecular Diagnostics is not included in the Dow Jones index

When was HTG Molecular Diagnostics's last earnings report?

HTG Molecular Diagnostics's most recent earnings report was on 10 November 2021

When does HTG Molecular Diagnostics report earnings?

The date for HTG Molecular Diagnostics's next earnings report has not been announced yet

Should I buy HTG Molecular Diagnostics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions